- Home
- COEP vs PMAX Comparison
COEP vs PMAX Comparison
Compare COEP & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COEP | PMAX |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 4.5M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | COEP | PMAX |
|---|---|---|
| Price | $14.67 | $2.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 108.4K | ★ 1.7M |
| Earning Date | 11-14-2025 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $500,996.00 | ★ $4,799,100.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $1.56 |
| 52 Week High | $21.41 | $24.36 |
Technical Indicators
Market Signals| Indicator | COEP | PMAX |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 48.33 |
| Support Level | $13.61 | $2.17 |
| Resistance Level | $14.88 | $2.97 |
| Average True Range (ATR) | 1.16 | 0.35 |
| MACD | -0.25 | -0.05 |
| Stochastic Oscillator | 17.40 | 28.10 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About PMAX Powell Max Limited
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.